|
|
MariMed Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization32.3 mln
Float336 mln
Earnings Date11/05/2026
Relative Strength
15
/ 100
Significantly lagging
Pre-Tax Margin
-6%
Marginally loss-making
Key Fundamentals
EPS-0.06
ROE-28.56
RPS0.58
ROIC-1.20
ROA-7.40
Interest Cover-0.19
EBITDA, mln13.00
EV / EBITDA12.41
EV / EBIT-52.95
Revenue, mln226
EV / Revenue0.72
Quote Details
Last
0.07
Change
-0.01 (-12.5%)
Open
0.07
Volume
14,000
Turnover
980
Average Volume
14,226
Financial Ratios
Pre-Tax Profit Margin-6
Leverage Ratio4.37
Current Ratio0.92
Price / Book0.66
Price / Tangible Book10.00
Price / Cash Flow2.33
Price / Free Cash Flow3.57
Debt / Equity2.16
Price / Sales0.17
Financial Strength
Altman Z-Score-0.08
Piotroski F-Score
5
/ 9
Beneish M-Score-2.83
Price to Intrinsic Value0.59
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-12.5% |
27
/ 100
 |
| 1 Month |
-33.33% |
24
/ 100
 |
| 2 Months |
-33.33% |
35
/ 100
 |
| 6 Months |
-46.15% |
42
/ 100
 |
| 1 Year |
-41.67% |
43
/ 100
|
|
| |
